Fostair NEXThaler

Description

Fostair NEXThaler contains beclometasone dipropionate, an inhaled corticosteroid, with formoterol, a long-acting beta-2 agonist, in a dry powder device rather than a pressurised inhaler. The steroid reduces inflammation in the airways and formoterol relaxes the muscle around them, so it is used as regular treatment for asthma where a combination is appropriate, and at the lower strength in chronic obstructive pulmonary disease.

The beclometasone is extrafine, so doses are not interchangeable with other beclometasone inhalers. To take a dose you open the cover fully, breathe in strongly and deeply through the mouthpiece, then close the cover; the dose counter moves only once the dose has been inhaled. Rinse your mouth with water afterwards. Tell your prescriber about heart rhythm problems, high blood pressure, thyroid disease, diabetes or a low blood potassium level.

• Combination inhaler: extrafine beclometasone with formoterol
• Dry powder NEXThaler device, breath-actuated with a dose counter
• Supplied as 100/6mcg and 200/6mcg per inhalation
• Doses are not interchangeable with other beclometasone inhalers
• Rinse your mouth with water after each dose
• Only use it as a reliever if your prescriber has set that up